project id: TCGA-STAD; case submitter id: TCGA-BR-8487; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; state: released; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.09; rna integrity number: 8.7; age at index: 64; days to birth: -23400; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1948; age at diagnosis: 23400; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage IIA; ajcc pathologic t: T3; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 34.0; icd 10 code: C16.3; last known disease status: not reported; morphology: 8140/3; primary diagnosis: Adenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Gastric antrum; synchronous malignancy: No; tissue or organ of origin: Gastric antrum; tumor grade: Not Reported; year of diagnosis: 2012; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; weight: 44.0; composition: Not Reported; days to sample procurement: 0; intermediate dimension: 1.6; longest dimension: 2.2; oct embedded: No; shortest dimension: 0.5; portion submitter id: TCGA-BR-8487-01A-11; percent lymphocyte infiltration: 2.0; percent monocyte infiltration: 2.0; percent necrosis: 1.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 99.0; percent tumor nuclei: 90.0;